CEACAM5 and neoplasm: So far, carcinoembryonic antigen (CEA) and CA19-9 are routinely used serum tumor biomarkers in clinical practice, but their sensitivity and specificity are not high, and they still have some limitations in the diagnosis and therapy of GC [4, 5].